perkinelmer inc agreed to buy biolegend a privately held maker of biomedical research tools for covid19 and other illnesses for about 525 billion in shares and cash the acquisition the largestever for waltham massachusettsbased perkinelmer is expected to close by the end of this year subject to regulatory approvals the companies said in a statement monday